Aquestive Therapeutics (AQST) Revenue (2017 - 2026)
Aquestive Therapeutics (AQST) recorded Revenue of $13.82 million in Q2 2026, up 38.1% from $10 million a year earlier but down 4.3% from the prior quarter.
Aquestive Therapeutics (AQST) Revenue (2017 - 2026) Analysis & Trends
On a TTM basis, Aquestive Therapeutics' Revenue came in at $54.09 million as of Jun 30, 2026, up 22.6% year-over-year; for FY2025, it came in at $44.55 million, down 22.6% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $57.56 million in FY2024 (+13.8%), $50.58 million in FY2023 (+6.1%), $47.68 million in FY2022 (-6.2%) and $50.83 million in FY2021 (+10.9%).
- Quarterly Revenue has ranged from $8.72 million in Q1 2025 to $20.1 million in Q2 2024 over the past five years.
- On a year-over-year basis, Revenue has increased for three consecutive quarters, with growth averaging 3.0% over the last eight quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 65.7% in Q1 2026, against a decline of 50.2% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.45 million (Q1 2026), $13.02 million (Q4 2025) and $12.81 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Aquestive Therapeutics | 581.12 Mn | 121.66 Mn | 9.80 Mn | 13.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.82 Mn |
| Mar 31, 2026 | 14.45 Mn |
| Dec 31, 2025 | 13.02 Mn |
| Sep 30, 2025 | 12.81 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 8.72 Mn |
| Dec 31, 2024 | 11.87 Mn |
| Sep 30, 2024 | 13.54 Mn |
| Jun 30, 2024 | 20.10 Mn |
| Mar 31, 2024 | 12.05 Mn |
| Dec 31, 2023 | 13.21 Mn |
| Sep 30, 2023 | 13.00 Mn |
| Jun 30, 2023 | 13.24 Mn |
| Mar 31, 2023 | 11.13 Mn |
| Dec 31, 2022 | 10.68 Mn |
| Sep 30, 2022 | 11.46 Mn |
| Jun 30, 2022 | 13.27 Mn |
| Mar 31, 2022 | 12.27 Mn |
| Dec 31, 2021 | 11.08 Mn |
| Sep 30, 2021 | 13.29 Mn |
Aquestive Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AQST&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();